Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -7.44
- Piotroski Score 3.00
- Grade Neutral
- Symbol (LYRA)
- Company Lyra Therapeutics, Inc.
- Price $0.27
- Changes Percentage (1.71%)
- Change -$0
- Day Low $0.26
- Day High $0.27
- Year High $6.79
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.50
- High Stock Price Target $0.50
- Low Stock Price Target $0.50
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.17
- Trailing P/E Ratio -0.27
- Forward P/E Ratio -0.27
- P/E Growth -0.27
- Net Income $-62,680,000
Income Statement
Quarterly
Annual
Latest News of LYRA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Top transfers: Lyra Drive business sells for $10 million
Top property transfers in Franklin, Delaware, Fairfield, and Licking counties from July 15-19 include sales like $3.83M in Gahanna, $2.38M in Columbus, and $1.8M in Columbus. Other notable transaction...
By Yahoo! Finance | 3 months ago
